Stop Retinal Ganglion Cell Dysfunction Study
Condition: GlaucomaInterventions: Drug: Latanoprost; Drug: Bimatoprost; Drug: Travoprost; Drug: Timolol; Drug: Dorzolamide; Drug: Brinzolamide; Drug: Acetazolamide; Drug: MethazolamideSponsors: University of Miami; National Eye Institute (NEI)Recruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 10, 2015 Category: Research Source Type: clinical trials
Stop Retinal Ganglion Cell Dysfunction Study
Condition: GlaucomaInterventions: Drug: Latanoprost; Drug: Bimatoprost; Drug: Travoprost; Drug: Timolol; Drug: Dorzolamide; Drug: Brinzolamide; Drug: Acetazolamide; Drug: MethazolamideSponsors: University of Miami; National Eye Institute (NEI)Recruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 10, 2015 Category: Research Source Type: clinical trials
A Parallel-Arm, Randomized, Dose-Ranging Study of ENV515 Travoprost Extended-Release (XR) in Subjects With Bilateral Ocular Hypertension or Early Primary Open-Angle Glaucoma
Condition: Glaucoma and Ocular HypertensionInterventions: Drug: ENV515 Travoprost XR; Drug: TRAVATAN ZSponsor: Envisia TherapeuticsRecruiting - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2015 Category: Research Source Type: clinical trials
6-Week Proof-of-Concept Study of Travoprost/Brinzolamide Ophthalmic Suspension in Subjects With Open-Angle Glaucoma or Ocular Hypertension
Conditions: Glaucoma; Ocular HypertensionInterventions: Drug: Dose Level A / Brinzolamide 1% ophthalmic suspension; Drug: Dose Level B / Brinzolamide 1% ophthalmic suspension; Drug: Dose Level C / Brinzolamide 1% ophthalmic suspension; Drug: Brinzolamide 1% ophthalmic suspension AZOPT®; Drug: Travoprost 0.004% ophthalmic solution TRAVATAN Z®; Drug: Travoprost solution vehicle; Drug: Brinzolamide suspension vehicleSponsor: Alcon ResearchActive, not recruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 15, 2014 Category: Research Source Type: clinical trials
6-Week Proof-of-Concept Study of Travoprost/Brinzolamide Ophthalmic Suspension in Subjects With Open-Angle Glaucoma or Ocular Hypertension
Conditions: Glaucoma; Ocular HypertensionInterventions: Drug: Dose Level A / Brinzolamide 1% ophthalmic suspension; Drug: Dose Level B / Brinzolamide 1% ophthalmic suspension; Drug: Dose Level C / Brinzolamide 1% ophthalmic suspension; Drug: Brinzolamide 1% ophthalmic suspension AZOPT®; Drug: Travoprost 0.004% ophthalmic solution TRAVATAN Z®; Drug: Travoprost solution vehicle; Drug: Brinzolamide suspension vehicleSponsor: Alcon ResearchCompleted - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 14, 2014 Category: Research Source Type: clinical trials
